These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 24962755)

  • 1. A recombinant rabies vaccine expressing the trimeric form of the glycoprotein confers enhanced immunogenicity and protection in outbred mice.
    Koraka P; Bosch BJ; Cox M; Chubet R; Amerongen Gv; Lövgren-Bengtsson K; Martina BE; Roose J; Rottier PJ; Osterhaus AD
    Vaccine; 2014 Aug; 32(36):4644-50. PubMed ID: 24962755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimeric rabies virus-like particles containing membrane-anchored GM-CSF enhances the immune response against rabies virus.
    Kang H; Qi Y; Wang H; Zheng X; Gao Y; Li N; Yang S; Xia X
    Viruses; 2015 Mar; 7(3):1134-52. PubMed ID: 25768031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A nucleoside-modified mRNA vaccine forming rabies virus-like particle elicits strong cellular and humoral immune responses against rabies virus infection in mice.
    Liu J; Sun J; Ding X; Liu W; Wang Y; Wang Z; Peng H; Zhang Y; Su W; Jiang C
    Emerg Microbes Infect; 2024 Dec; 13(1):2389115. PubMed ID: 39129566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and immunogenicity of a recombinant pseudotype baculovirus expressing the glycoprotein of rabies virus in mice.
    Huang H; Xiao S; Qin J; Jiang Y; Yang S; Li T; Gao Y; Li Z; Li T; Su X; Ruan Y; Xu F; Wang H; Chen H; Xia X
    Arch Virol; 2011 May; 156(5):753-8. PubMed ID: 21221673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two potential recombinant rabies vaccines expressing canine parvovirus virion protein 2 induce immunogenicity to canine parvovirus and rabies virus.
    Luo J; Shi H; Tan Y; Niu X; Long T; Zhao J; Tian Q; Wang Y; Chen H; Guo X
    Vaccine; 2016 Aug; 34(37):4392-8. PubMed ID: 27449079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the protective efficacy between single and combination of recombinant adenoviruses expressing complete and truncated glycoprotein, and nucleoprotein of the pathogenic street rabies virus in mice.
    Kim HH; Yang DK; Nah JJ; Song JY; Cho IS
    Virol J; 2017 Jun; 14(1):122. PubMed ID: 28646885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycoprotein from street rabies virus BD06 induces early and robust immune responses when expressed from a non-replicative adenovirus recombinant.
    Wang S; Sun C; Zhang S; Zhang X; Liu Y; Wang Y; Zhang F; Wu X; Hu R
    Arch Virol; 2015 Sep; 160(9):2315-23. PubMed ID: 26143474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant canine distemper virus serves as bivalent live vaccine against rabies and canine distemper.
    Wang X; Feng N; Ge J; Shuai L; Peng L; Gao Y; Yang S; Xia X; Bu Z
    Vaccine; 2012 Jul; 30(34):5067-72. PubMed ID: 22698451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative approach between heterologous prime-boost vaccination strategy and DNA vaccinations for rabies.
    Borhani K; Ajorloo M; Bamdad T; Mozhgani SH; Ghaderi M; Gholami AR
    Arch Iran Med; 2015 Apr; 18(4):223-7. PubMed ID: 25841942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of ORFV-based vectors expressing the rabies virus glycoprotein in livestock species.
    Martins M; Joshi LR; Rodrigues FS; Anziliero D; Frandoloso R; Kutish GF; Rock DL; Weiblen R; Flores EF; Diel DG
    Virology; 2017 Nov; 511():229-239. PubMed ID: 28898730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the immunogenicity of two inactivated recombinant rabies viruses overexpressing the glycoprotein.
    Navid MT; Li Y; Zhou M; Cui M; Fu ZF; Tang L; Zhao L
    Arch Virol; 2016 Oct; 161(10):2863-70. PubMed ID: 27438075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice.
    Li J; Faber M; Papaneri A; Faber ML; McGettigan JP; Schnell MJ; Dietzschold B
    Virology; 2006 Dec 5-20; 356(1-2):147-54. PubMed ID: 16938327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An electrochemiluminescence assay for analysis of rabies virus glycoprotein content in rabies vaccines.
    Smith TG; Ellison JA; Ma X; Kuzmina N; Carson WC; Rupprecht CE
    Vaccine; 2013 Jul; 31(33):3333-8. PubMed ID: 23742991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new rabies vaccine based on a recombinant ORF virus (parapoxvirus) expressing the rabies virus glycoprotein.
    Amann R; Rohde J; Wulle U; Conlee D; Raue R; Martinon O; Rziha HJ
    J Virol; 2013 Feb; 87(3):1618-30. PubMed ID: 23175365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel rabies vaccine based on a recombinant parainfluenza virus 5 expressing rabies virus glycoprotein.
    Chen Z; Zhou M; Gao X; Zhang G; Ren G; Gnanadurai CW; Fu ZF; He B
    J Virol; 2013 Mar; 87(6):2986-93. PubMed ID: 23269806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective efficacy in mice of post-exposure vaccination with vaccinia virus recombinant expressing either rabies virus glycoprotein or nucleoprotein.
    Fujii H; Takita-Sonoda Y; Mifune K; Hirai K; Nishizono A; Mannen K
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1339-44. PubMed ID: 8207400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination.
    Shuai L; Feng N; Wang X; Ge J; Wen Z; Chen W; Qin L; Xia X; Bu Z
    Antiviral Res; 2015 Sep; 121():9-15. PubMed ID: 26093157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhabdovirus-based vaccine platforms against henipaviruses.
    Kurup D; Wirblich C; Feldmann H; Marzi A; Schnell MJ
    J Virol; 2015 Jan; 89(1):144-54. PubMed ID: 25320306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immune response of mice to replication-defective recombinant adenovirus containing glycoprotein gene of rabies virus 3aG strain].
    Li W; Zhang Y; Wang S
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Mar; 15(1):61-5. PubMed ID: 12526306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of antibodies against canine adenovirus (CAV) type 2 in domestic dog populations in South Africa precludes the use of CAV-based recombinant rabies vaccines.
    Wright N; Jackson FR; Niezgoda M; Ellison JA; Rupprecht CE; Nel LH
    Vaccine; 2013 Aug; 31(38):4177-82. PubMed ID: 23867013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.